These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6144626)

  • 1. Sudden death and antipsychotic drugs.
    Brown RP; Kocsis JH
    Hosp Community Psychiatry; 1984 May; 35(5):486-91. PubMed ID: 6144626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland.
    Mehtonen OP; Aranko K; Mälkonen L; Vapaatalo H
    Acta Psychiatr Scand; 1991 Jul; 84(1):58-64. PubMed ID: 1681681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular side effects of phenothiazines and tricyclic antidepressants. A review with precautionary measures.
    Lipscomb PA
    Postgrad Med; 1980 Mar; 67(3):189-92, 195-6. PubMed ID: 7355133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of sudden death in psychiatric patients with special reference to phenothiazine therapy: forensic pathology.
    Laposata EA; Hale P; Poklis A
    J Forensic Sci; 1988 Mar; 33(2):432-40. PubMed ID: 2897420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sudden death in psychiatric patients].
    Levkovitz Y; Levy A; Levin Y; Neumann M
    Harefuah; 1990 Nov; 119(10):323-6. PubMed ID: 1980904
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps.
    Zhu J; Hou W; Xu Y; Ji F; Wang G; Chen C; Lin C; Lin X; Li J; Zhuo C; Shao M
    Psychiatry Res; 2019 Nov; 281():112598. PubMed ID: 31622875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major tranquilizers and heart disease: to use or not to use.
    Levenson AJ; Beard OW; Murphy ML
    Geriatrics; 1980 Oct; 35(10):55-7, 61. PubMed ID: 6108281
    [No Abstract]   [Full Text] [Related]  

  • 8. Potassium, antipsychotic agents, arrhythmias, and sudden death.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1998 Dec; 18(6):427-8. PubMed ID: 9864072
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac function in patients treated with phenothiazines. Comparison with quinidine.
    Samet JM; Surawicz B
    J Clin Pharmacol; 1974; 14(11-12):588-96. PubMed ID: 4154951
    [No Abstract]   [Full Text] [Related]  

  • 10. Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature.
    Frassati D; Tabib A; Lachaux B; Giloux N; Daléry J; Vittori F; Charvet D; Barel C; Bui-Xuan B; Mégard R; Jenoudet LP; Descotes J; Vial T; Timour Q
    Can J Psychiatry; 2004 Feb; 49(2):100-5. PubMed ID: 15065743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone: ventricular arrhythmia and sudden death (continued).
    Prescrire Int; 2012 Jul; 21(129):183. PubMed ID: 22852288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe ventricular arrhythmia and sudden death on neuroleptics.
    Prescrire Int; 2002 Oct; 11(61):146-50. PubMed ID: 12378746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of risperidone on QT interval and QT dispersion in the elderly.
    Yerrabolu M; Prabhudesai S; Tawam M; Winter L; Kamalesh M
    Heart Dis; 2000; 2(1):10-2. PubMed ID: 11728238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic treatment and unexpected death].
    Ungvári G
    Fortschr Neurol Psychiatr; 1982 Aug; 50(8):267-73. PubMed ID: 6127297
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of phenothiazines: a review.
    Habibzadeh MA
    Ariz Med; 1979 Jul; 36(7):518-20. PubMed ID: 526158
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular adverse effects of antipsychotic drugs.
    Buckley NA; Sanders P
    Drug Saf; 2000 Sep; 23(3):215-28. PubMed ID: 11005704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Thioridazine: re-evaluating the risk/benefit equation.
    Timell AM
    Ann Clin Psychiatry; 2003 Jun; 15(2):131. PubMed ID: 12938870
    [No Abstract]   [Full Text] [Related]  

  • 18. [An evaluation of the therapeutic safety of anti-psychotic agents: analysis of 104 mortality cases in the past 30 years].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):267-70, 318. PubMed ID: 2906856
    [No Abstract]   [Full Text] [Related]  

  • 19. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUDDEN DEATH DURING TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
    HOLLISTER LE; KOSEK JC
    JAMA; 1965 Jun; 192():1035-8. PubMed ID: 14293499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.